MC
ABMD

Maverick Capital’s Abiomed Inc ABMD Stock Holding History

Maverick Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,007
Closed -$247K – 460
2022
Q3 		$247K Buy
+1,007
New +$272K 0.01% 275
2022
Q2 		– Sell
-792
Closed -$262K – 283
2022
Q1 		$262K Buy
792
+494
+166% +$152K ﹤0.01% 195
2021
Q4 		$107K Sell
298
-5,049
-94% -$1.71M ﹤0.01% 197
2021
Q3 		$1.74M Sell
5,347
-2,508
-32% -$850K 0.02% 196
2021
Q2 		$2.45M Buy
7,855
+4,966
+172% +$1.52M 0.02% 145
2021
Q1 		$921K Sell
2,889
-3,159
-52% -$1.01M 0.01% 269
2020
Q4 		$1.96M Buy
6,048
+3,494
+137% +$966K 0.03% 134
2020
Q3 		$708K Sell
2,554
-7,419
-74% -$2.14M 0.01% 367
2020
Q2 		$2.41M Buy
+9,973
New +$2M 0.05% 144
2018
Q1 		– Sell
-32,580
Closed -$6.11M – 264
2017
Q4 		$6.11M Buy
+32,580
New +$6.08M 0.08% 135

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Maverick Capital's ABMD Position: Q4 2022 in Review

Maverick Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,007 shares — an estimated $247K sold.

Maverick Capital first reported a position in ABMD in Q4 2017 and held it in 10 quarters. The position peaked at $6.11M in Q4 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Maverick Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Maverick Capital sold 1,007 Abiomed Inc shares in Q4 2022, an estimated $247K.
  • Maverick Capital first reported a position in Abiomed Inc in Q4 2017 and held it in 10 quarters.
  • Maverick Capital's Abiomed Inc position peaked at $6.11M in Q4 2017.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Maverick Capital's 13F filing for Q4 2022, filed 14 Feb 2023.